BOSTON– Atomic has officially launched as a first-of-its-kind service platform for MedTech startups, designed to bridge the gap between breakthrough ideas and investor-ready ventures.
Formed through a collaboration between three industry leaders—Goodwin (legal), Three Bridges (business and financial), and Match Health Collective (strategic marketing and design)—Atomic provides an integrated suite of legal, financial, and strategic services that help early-stage MedTech founders prepare for venture capital investment.
In an increasingly competitive investment landscape, early-stage MedTech companies are facing higher expectations from investors, who now demand clear market readiness and operational foundations before committing funding. Atomic’s approach addresses this challenge directly, equipping founders with the tools, materials, and frameworks required to present a complete, fundable business case.
Unlike traditional accelerators or advisory firms, Atomic operates on a fixed-fee, zero-equity model, allowing founders to retain full ownership while gaining access to deep expertise across critical business functions. The program delivers tangible outcomes such as intellectual property strategies, detailed financial models, investor presentations, and market-facing branding assets. Tailored for a limited number of high-potential companies, Atomic provides a hands-on partnership to help startups reach fundraising milestones more efficiently and scale sustainably.
“After supporting countless VC financings over the years, the biggest challenge we see for MedTech companies that come to us is the significant gap between innovative technology and a real fundable business,” said Marty Gomez, partner at Goodwin and co-founder of Atomic. “By aligning legal, financial, and market strategy from the outset, we help a select group of founders show up ready for investors and positioned to lead the next generation of MedTech innovation.”
Atomic’s model emphasizes long-term collaboration rather than transactional engagement, supporting founders not only through their initial raise but also as they expand and mature. The company’s first program graduate, Contrario Medical, successfully raised $2.3 million in seed funding within five weeks of completion, underscoring the model’s effectiveness in accelerating fundraising readiness.
Atomic’s structured program includes a zero-equity framework, complete investor-ready data rooms, and customized support based on each company’s stage and goals. Participants also gain continued access to Atomic’s investor network, industry events, and media visibility opportunities—ensuring that the journey from concept to commercialization is guided by expert alignment every step of the way.
